BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37762500)

  • 1. Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis.
    Yoshida M; Funasaka Y; Saeki H; Yamamoto M; Kanda N
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Gut Microbiome in Psoriasis: Oral Administration of
    Okada K; Matsushima Y; Mizutani K; Yamanaka K
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
    Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
    Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
    Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
    Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rutaecarpine ameliorates imiquimod-induced psoriasis-like dermatitis in mice associated with alterations in the gut microbiota.
    Li Y; Tan Z; Li W; Li Z; Zhang G
    Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):345-355. PubMed ID: 38419497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
    Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice.
    Higashi Y; Yamakuchi M; Fukushige T; Ibusuki A; Hashiguchi T; Kanekura T
    Exp Dermatol; 2018 Feb; 27(2):178-184. PubMed ID: 29247486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosylation deficiency enhances imiquimod-induced psoriasis-like skin inflammation by promoting CXCL1 expression.
    Li N; Lee Y; Suh JH; Oh JH; Jin SP; Lee DH; Chung JH
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166988. PubMed ID: 38070583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
    Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
    Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
    Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
    Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice.
    Zhou Y; Han D; Follansbee T; Wu X; Yu S; Wang B; Shi Z; Domocos DT; Carstens M; Carstens E; Hwang ST
    J Cell Mol Med; 2019 Jul; 23(7):4819-4828. PubMed ID: 31111624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation.
    Hsu PY; Yang HJ; Yang TH; Su CC
    Exp Dermatol; 2018 Nov; 27(11):1273-1279. PubMed ID: 30221419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1β/IL-23p40 production.
    Wang Y; Li P; Zhang L; Fu J; Di T; Li N; Meng Y; Guo J; Zhao J
    J Leukoc Biol; 2020 Jul; 108(1):267-281. PubMed ID: 32421901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells.
    Nakamizo S; Honda T; Adachi A; Nagatake T; Kunisawa J; Kitoh A; Otsuka A; Dainichi T; Nomura T; Ginhoux F; Ikuta K; Egawa G; Kabashima K
    Sci Rep; 2017 Oct; 7(1):14076. PubMed ID: 29074858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
    Sun J; Zhao Y; Hu J
    PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice.
    Salman HR; Al-Zubaidy AA; Abbas AH; Zigam QA
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):599-616. PubMed ID: 37490123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    Zhao K; Pu S; Sun L; Zhou D
    Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.